TrialLeukemia2017

A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes.

U Platzbecker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.